Aprameya Enginee vs Q-Line Biotech
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Q-Line Biotech currently has the stronger revenue growth signal.
Aprameya Enginee and Q-Line Biotech show active capex signals based on earnings call analysis.
Aprameya Enginee show fundraising activity or capital structure signals.
| Metric | Aprameya Enginee | Q-Line Biotech |
|---|---|---|
| Current Price | ₹86.5 | ₹600.55 |
| Market Cap | ₹164.69 Cr. | ₹1,400.97 Cr. |
| Industry | Healthcare Equipment & Supplies | — |
| P/E Ratio | 32.68 | 24.73 |
| ROE (%) | 7.54 | 25.97 |
| Debt/Equity | 0.1 | 0.92 |
| Sales Growth 5Y (%) | 16.12 | — |
| Profit Growth 5Y (%) | -62.16 | — |
| Promoter Holding (%) | 74.05 | 67.51 |
| Revenue Rank | Rank 3 | Rank 2 |
| Margin Rank | Rank 3 | Rank 1 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | Yes | No information |